Osteoarthritis, Knee Clinical Trial
Official title:
A Multicenter, Single- Arm Postmarket Study of the Construct Validity of Community Walking Speed Data Collected Remotely With the Canary canturioTM te Tibial Extension
NCT number | NCT05539326 |
Other study ID # | POS-CTE-002P |
Secondary ID | |
Status | Completed |
Phase | |
First received | |
Last updated | |
Start date | December 29, 2022 |
Est. completion date | May 12, 2023 |
Verified date | September 2023 |
Source | Canary Medical |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Observational |
The purpose of this study is to determine the construct validity of the Canary Tibial Extension's measure of self-selected community walking speed. Construct validity will be assessed by the Pearson's correlation coefficient between self-selected community walking speed and the 4-meter walk test. The objective of this multicenter, prospective study is to demonstrate that remote measurement of community walking speed with the Canary canturioTM (CTE) tibial extension is correlated with the fast 4-meter walk test (4mWT).
Status | Completed |
Enrollment | 52 |
Est. completion date | May 12, 2023 |
Est. primary completion date | May 12, 2023 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | All |
Age group | 18 Years and older |
Eligibility | Inclusion Criteria: - Patient must be 18 years of age or older at the time of surgery - Patient is scheduled for or has undergone primary total knee arthroplasty using a Persona Personalized Knee System with Canary Tibial Extension (PIQ) TKA implant according to the appropriate surgical technique and IFU. - Patient must be willing and able to complete the protocol required follow-up - Patient has participated in the study-related informed consent process - Patient has a platform-compatible personal computer located in their dwelling with substantially reliable wireless internet access and a USB port Exclusion Criteria: - Simultaneous bilateral TKA - Staged bilateral TKA less than 6 months from indexed procedure - Patient is a current alcohol or drug abuser - Patient is known to be pregnant, breastfeeding, or considered a member of a protected class (e.g., prisoner, mentally incompetent, etc.) - Patient has a psychiatric illness or cognitive deficit that will not allow proper informed consent and participation in follow-up program - Patient has previous history of infection in the affected joint and/or a local or systemic infection that may affect the prosthetic joint - Patient with mental or neurologic conditions who are unwilling or incapable of following postoperative care instructions - Patient with Neuropathic Arthropathy - Patient has rheumatoid arthritis accompanied by an ulcer of the skin or a history of recurrent breakdown of the skin - Patient is undergoing procedures or treatments using ionizing radiation - Patient has a known or suspected sensitivity to one or more of the implant materials. - Patients with known orthopaedic lower extremity, spinal and/or neurologic conditions that could affect gait |
Country | Name | City | State |
---|---|---|---|
United States | Vail Summit Orthopaedics and Neurosurgery | Frisco | Colorado |
United States | Mississippi Sports Medicine and Orthopaedic Center | Jackson | Mississippi |
United States | Dr. Ballard | Oregon City | Oregon |
United States | Orthopaedic Surgery and Sports Medicine | San Antonio | Texas |
United States | South Bend Orthopaedics | South Bend | Indiana |
United States | Orthopedic NJ | Sparta | New Jersey |
Lead Sponsor | Collaborator |
---|---|
Canary Medical |
United States,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | 4 Meter Walk Test | A 4MWT test will be performed in the physician's clinic along a clear pathway of at least 8 in length in a designated area over solid flooring. The 8-m distance will be measured with a starting (0m) and an end point (8m) with additional marks at 2m and 6m to identify the 4m which is the timed portion of the test. A handheld, calibrated stopwatch will be used as the gold standard for measuring walking speed output during the 4 mWT, measuring the time it takes to complete the test. | 4 wks+2 weeks post TKA | |
Primary | Timed Up and Go Test *(TUG) | Patients may use a walking aid if needed. Patients will begin by sitting back in a standard armchair. Investigator will identify a line 3 meters (9.8 feet) away on the floor. When the investigator says "go" the patient will:
stand up from the chair walk to the line on the floor at a comfortable and safe walking speed turn and walk back to the chair at a comfortable and safe walking speed Sit down again A stopwatch will be used to record the time it takes from the initiation of the exam on the word "go" to the end of the exam when the patient's buttocks touch the seat. |
4 wks+2 weeks post TKA | |
Primary | Community Walking Speed | Average walking speed | 7 days prior to follow-up appoinment | |
Secondary | Numeric Pain Rating Scale | Patient Reported Outcome on level of Pain | wks+2 weeks post TKA | |
Secondary | Oxford Knee Score | Patient Reported Outcome on Clinical Function | wks+2 weeks post TKA | |
Secondary | KOOS Jr | Patient Reported Outcome on Clinical Function | 4wks+2 weeks post TKA | |
Secondary | Clinical Limping Evaluation | Self Evaluation of Limping | 4wks+2 weeks post TKA |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT03895489 -
Effectiveness of the Journey Total Knee Arthroplasty Versus Two Standard of Care Total Knee Arthroplasty Prostheses
|
N/A | |
Completed |
NCT03660943 -
A Clinical Study to Test Efficacy and Safety of Repeat Doses of CNTX-4975-05 in Patients With Osteoarthritis Knee Pain
|
Phase 3 | |
Completed |
NCT04531969 -
Comparison of Outpatient and Inpatient Spa Therapy
|
N/A | |
Completed |
NCT02848027 -
Correlating the Osteoarthritic Knee Microenvironment to Clinical Outcome After Treatment With Regenexx®SD Treatment
|
Phase 3 | |
Completed |
NCT05160246 -
The Instant Effect of Kinesiology Taping in Patients With Knee OA
|
N/A | |
Recruiting |
NCT06080763 -
Biomechanics and Clinical Outcomes in Responders and Non-Responders
|
||
Completed |
NCT03643588 -
The Comparison of HYAJOINT Plus and Hyalgan Hyaluronan Supplement for Knee Osteoarthritis Pain
|
N/A | |
Active, not recruiting |
NCT05100225 -
Efficacy and Safety Trial of PTP-001 (MOTYS) for Symptomatic Knee Osteoarthritis
|
Phase 2 | |
Active, not recruiting |
NCT04061733 -
New Hydroxyethyl Cellulose Hydrogel for the Treatment of the Pain of Knee Arthrosis
|
N/A | |
Completed |
NCT04051489 -
A Novel Smartphone Application for "Smart" Knee Osteoarthritis Trials
|
||
Recruiting |
NCT05546541 -
Epidemiology and Nutrition
|
||
Recruiting |
NCT05447767 -
Prediction AlgoriThm for regeneraTive Medicine Approach in knEe OA: New Decision-making Process Based on Patient pRofiliNg
|
Phase 2 | |
Not yet recruiting |
NCT04448106 -
Autologous Adipose Tissue-Derived Mesenchymal Stem Cells (AdMSCs) for Osteoarthritis
|
Phase 2 | |
Not yet recruiting |
NCT03225911 -
Effect of a Lateral Wedge Insole and Simple Knee Sleeve in Individuals With Knee Osteoarthritis
|
N/A | |
Completed |
NCT05070871 -
A Clinical Trial Investigating the Effect of Salmon Bone Meal on Osteoarthritis Among Men and Women
|
N/A | |
Completed |
NCT05703087 -
Positive Cueing in Knee Arthroplasty.
|
N/A | |
Not yet recruiting |
NCT06042426 -
Effects of Perioperative Intravenous Dexamethasone in Clinical Outcomes After Total Knee Arthroplasty in a Hispanic Population
|
Phase 4 | |
Completed |
NCT02901964 -
Effect of Strengthening the Hip Abductor in Patients With Knee Osteoarthritis: Randomized Controlled Trial
|
N/A | |
Completed |
NCT03037489 -
A Study to Evaluate Safety and Tolerability of MIV-711 in Osteoarthritis Patients
|
Phase 2 | |
Not yet recruiting |
NCT02854176 -
Somatosensory Stimulation in Knee Osteoarthritis
|
Phase 2 |